Second‐generation capsule endoscopy for the detection of colorectal polyps: An updated systematic review and comparative meta‐analysis of prospective studies
Colorectal Disease · 2026-01 · 28 (1)
DOI: 10.1111/codi.70362 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Colorectal Disease, online erschienen am 20.01.2026. Verfasst von Cauã Ferreira Câmara und 8 weiteren Autor:innen. Beteiligte Einrichtung: Universidade Federal do Ceará, Fortaleza, Brazil. Hauptthemen laut MEDLINE: Capsule Endoscopy, Colonic Polyps, Colorectal Neoplasms, Early Detection of Cancer. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
Colorectal cancer (CRC) is the third most common cancer worldwide and the second leading cause of cancer‐related death. Colonoscopy (CO) is the gold standard for screening, but its invasive nature and low adherence limit its use. Second‐generation capsule endoscopy (CCE‐2) emerges as a non‐invasive alternative. This study aimed to evaluate the diagnostic accuracy of CCE‐2 in detecting colorectal polyps, using CO as the reference standard.
Methods
A systematic review and meta‐analysis of prospective studies in adults undergoing CCE‐2 followed by CO was performed. Searches were conducted in PubMed, EMBASE and Cochrane up to May 2025. Diagnostic accuracy metrics were pooled using a Bayesian bivariate model with construction of HSROC curves. To assess clinical impact, a fictitious cohort of 1000 patients was simulated based on polyp prevalence and submitted to decision curve analysis (DCA).
Results
Twelve studies including 4316 patients were analysed. CCE‐2 demonstrated sensitivity/specificity of 0.89/0.94 for polyps ≥6 mm and 0.91/0.98 for ≥10 mm. In FIT‐positive patients, performance was superior. In the simulated cohort, CCE‐2 showed greater net benefit from a 20% pre‐test probability threshold of a patient to have a polyp of any size, surpassing the universal CO strategy, avoiding unnecessary colonoscopies to make this diagnostic.
Conclusion
CCE‐2 is a non‐invasive, safe and accurate alternative for CRC screening, with potential to increase adherence, particularly in patients with contraindications or refusal of CO. However, the lack of therapeutic capability and absence of evidence regarding mortality reduction limit its role as a first‐line tool. Randomized clinical trials are needed to consolidate its role in personalized screening.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Universidade Federal do Ceará, Fortaleza, Brazil.
- Hospital Universitário Walter Cantídio, Fortaleza, Brazil.
ORCID-Profile: Cauã Ferreira Câmara
Zitieren
APA
Câmara, C. F., Passos, P. R. C., Cezar, E. C. L., Filho, J. N. L., Oliveira, R. M. A., de Paiva, C. Y. M., Quintela, A. O., de Andrade, A. F., & Veras, L. B. (2026). Second‐generation capsule endoscopy for the detection of colorectal polyps: An updated systematic review and comparative meta‐analysis of prospective studies. Colorectal Disease, 28(1). https://doi.org/10.1111/codi.70362
Vancouver
Câmara CF, Passos PRC, Cezar ECL, Filho JNL, Oliveira RMA, de Paiva CYM, et al. Second‐generation capsule endoscopy for the detection of colorectal polyps: An updated systematic review and comparative meta‐analysis of prospective studies. Colorectal Disease. 2026;28(1). doi:10.1111/codi.70362
BibTeX
@article{Cmara2026,
author = {Câmara, Cauã Ferreira and Passos, Pedro Robson Costa and Cezar, Ettore Carvalho Lopes and Filho, José Nilo de Lima and Oliveira, Rafael Mariano Araújo and de Paiva, Carlos Yuri Monteiro and Quintela, Adriely Oliveira and de Andrade, Alana Ferreira and Veras, Lara Burlamaqui},
title = {Second‐generation capsule endoscopy for the detection of colorectal polyps: An updated systematic review and comparative meta‐analysis of prospective studies},
journal = {Colorectal Disease},
year = {2026},
volume = {28},
number = {1},
doi = {10.1111/codi.70362}
}
EUVIMED